LEXX is Lexaria Bioscience Corp. (Healthcare) — a non-dividend-paying stock. Trading at $12.69. Market cap: $22M. Capital Quality Rank: 30/100 — Stagnant mediocrity.
Stock snapshot
| Price | $12.69 |
| Market cap | $22M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 30 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -359.4% |
| Revenue CAGR (3y) | 40.3% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Distress |
About LEXX
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Related non-dividend companies
Other non-dividend stocks investors research alongside LEXX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is LEXX's current stock price?
LEXX (Lexaria Bioscience Corp.) is currently trading at $12.69.
Does LEXX pay a dividend?
LEXX (Lexaria Bioscience Corp.) does not currently pay a regular dividend.
What is LEXX's Capital Quality Rank?
LEXX has a Capital Quality Rank of 30/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track LEXX in DiviDrip
Add LEXX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search LEXX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.